rs41286572
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000699461.1(MEG9):n.382-1649G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0657 in 534,412 control chromosomes in the GnomAD database, including 1,381 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.061 ( 342 hom., cov: 32)
Exomes 𝑓: 0.068 ( 1039 hom. )
Consequence
MEG9
ENST00000699461.1 intron
ENST00000699461.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0710
Publications
8 publications found
Genes affected
MEG9 (HGNC:43874): (maternally expressed 9)
MIR154 (HGNC:31541): (microRNA 154) microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.6).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0751 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MIR154 | NR_029704.1 | n.*6G>A | downstream_gene_variant | |||||
| MIR154 | unassigned_transcript_2437 | n.*54G>A | downstream_gene_variant | |||||
| MIR154 | unassigned_transcript_2438 | n.*18G>A | downstream_gene_variant |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0611 AC: 9289AN: 152124Hom.: 341 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
9289
AN:
152124
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0628 AC: 15742AN: 250856 AF XY: 0.0640 show subpopulations
GnomAD2 exomes
AF:
AC:
15742
AN:
250856
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0676 AC: 25818AN: 382170Hom.: 1039 Cov.: 0 AF XY: 0.0677 AC XY: 14730AN XY: 217556 show subpopulations
GnomAD4 exome
AF:
AC:
25818
AN:
382170
Hom.:
Cov.:
0
AF XY:
AC XY:
14730
AN XY:
217556
show subpopulations
African (AFR)
AF:
AC:
288
AN:
10508
American (AMR)
AF:
AC:
1184
AN:
36292
Ashkenazi Jewish (ASJ)
AF:
AC:
651
AN:
11724
East Asian (EAS)
AF:
AC:
408
AN:
13172
South Asian (SAS)
AF:
AC:
3722
AN:
66724
European-Finnish (FIN)
AF:
AC:
3206
AN:
32304
Middle Eastern (MID)
AF:
AC:
242
AN:
2806
European-Non Finnish (NFE)
AF:
AC:
14936
AN:
191928
Other (OTH)
AF:
AC:
1181
AN:
16712
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
1432
2863
4295
5726
7158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
104
208
312
416
520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0610 AC: 9290AN: 152242Hom.: 342 Cov.: 32 AF XY: 0.0614 AC XY: 4567AN XY: 74436 show subpopulations
GnomAD4 genome
AF:
AC:
9290
AN:
152242
Hom.:
Cov.:
32
AF XY:
AC XY:
4567
AN XY:
74436
show subpopulations
African (AFR)
AF:
AC:
1147
AN:
41562
American (AMR)
AF:
AC:
896
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
AC:
217
AN:
3468
East Asian (EAS)
AF:
AC:
154
AN:
5178
South Asian (SAS)
AF:
AC:
266
AN:
4814
European-Finnish (FIN)
AF:
AC:
1049
AN:
10592
Middle Eastern (MID)
AF:
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
AC:
5227
AN:
68018
Other (OTH)
AF:
AC:
138
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
449
897
1346
1794
2243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
163
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.